Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance.

Nucleic acids research

Germe T, Vörös J, Jeannot F, Taillier T, Stavenger RA, Bacqué E, Maxwell A, Bax BD.
PMID: 29596599
Nucleic Acids Res. 2018 May 04;46(8):4325. doi: 10.1093/nar/gky241.

No abstract available.

Cite
Germe T, Vörös J, Jeannot F, et al. A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance. Nucleic Acids Res. 2018;46(8):4325doi: 10.1093/nar/gky241.
Germe, T., Vörös, J., Jeannot, F., Taillier, T., Stavenger, R. A., Bacqué, E., Maxwell, A., & Bax, B. D. (2018). A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance. Nucleic acids research, 46(8), 4325. https://doi.org/10.1093/nar/gky241
Germe, Thomas, et al. "A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance." Nucleic acids research vol. 46,8 (2018): 4325. doi: https://doi.org/10.1093/nar/gky241
Germe T, Vörös J, Jeannot F, Taillier T, Stavenger RA, Bacqué E, Maxwell A, Bax BD. A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance. Nucleic Acids Res. 2018 May 04;46(8):4325. doi: 10.1093/nar/gky241. PMID: 29596599; PMCID: PMC5934632.
Copy Download .nbib Format: NLM
[Frosted branch angiitis-Rare differential diagnosis of retinal vasculitis].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft

Farese G, Lorenz AT, Bocqué C, Szurman P, Rickmann A.
PMID: 35006309
Ophthalmologe. 2022 Jan 10; doi: 10.1007/s00347-021-01563-6. Epub 2022 Jan 10.

No abstract available.

Cite
Farese G, Lorenz AT, Bocqué C, et al. Frosted-Branch-Angiitis – seltene Differenzialdiagnose einer retinalen Vaskulitis. [Frosted branch angiitis-Rare differential diagnosis of retinal vasculitis]. Ophthalmologe. 2022;doi: 10.1007/s00347-021-01563-6.
Farese, G., Lorenz, A. T., Bocqué, C., Szurman, P., & Rickmann, A. (2022). Frosted-Branch-Angiitis – seltene Differenzialdiagnose einer retinalen Vaskulitis. [Frosted branch angiitis-Rare differential diagnosis of retinal vasculitis]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, . https://doi.org/10.1007/s00347-021-01563-6
Farese, Gerardo, et al. "Frosted-Branch-Angiitis – seltene Differenzialdiagnose einer retinalen Vaskulitis." [Frosted branch angiitis-Rare differential diagnosis of retinal vasculitis]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft vol. (2022). doi: https://doi.org/10.1007/s00347-021-01563-6
Farese G, Lorenz AT, Bocqué C, Szurman P, Rickmann A. Frosted-Branch-Angiitis – seltene Differenzialdiagnose einer retinalen Vaskulitis. [Frosted branch angiitis-Rare differential diagnosis of retinal vasculitis]. Ophthalmologe. 2022 Jan 10; doi: 10.1007/s00347-021-01563-6. Epub 2022 Jan 10. German. PMID: 35006309.
Copy Download .nbib Format: NLM
Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial.

Lancet (London, England)

Little P, Francis NA, Stuart B, O'Reilly G, Thompson N, Becque T, Hay AD, Wang K, Sharland M, Harnden A, Yao G, Raftery J, Zhu S, Little J, Hookham C, Rowley K, Euden J, Harman K, Coenen S, Read RC, Woods C, Butler CC, Faust SN, Leydon G, Wan M, Hood K, Whitehurst J, Richards-Hall S, Smith P, Thomas M, Moore M, Verheij T.
PMID: 34562391
Lancet. 2021 Oct 16;398(10309):1417-1426. doi: 10.1016/S0140-6736(21)01431-8. Epub 2021 Sep 22.

BACKGROUND: Antibiotic resistance is a global public health threat. Antibiotics are very commonly prescribed for children presenting with uncomplicated lower respiratory tract infections (LRTIs), but there is little evidence from randomised controlled trials of the effectiveness of antibiotics, both...

Cite
Little P, Francis NA, Stuart B, et al. Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial. Lancet. 2021;398(10309):1417-1426doi: 10.1016/S0140-6736(21)01431-8.
Little, P., Francis, N. A., Stuart, B., O'Reilly, G., Thompson, N., Becque, T., Hay, A. D., Wang, K., Sharland, M., Harnden, A., Yao, G., Raftery, J., Zhu, S., Little, J., Hookham, C., Rowley, K., Euden, J., Harman, K., Coenen, S., Read, R. C., Woods, C., Butler, C. C., Faust, S. N., Leydon, G., Wan, M., Hood, K., Whitehurst, J., Richards-Hall, S., Smith, P., Thomas, M., Moore, M., & Verheij, T. (2021). Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial. Lancet (London, England), 398(10309), 1417-1426. https://doi.org/10.1016/S0140-6736(21)01431-8
Little, Paul, et al. "Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial." Lancet (London, England) vol. 398,10309 (2021): 1417-1426. doi: https://doi.org/10.1016/S0140-6736(21)01431-8
Little P, Francis NA, Stuart B, O'Reilly G, Thompson N, Becque T, Hay AD, Wang K, Sharland M, Harnden A, Yao G, Raftery J, Zhu S, Little J, Hookham C, Rowley K, Euden J, Harman K, Coenen S, Read RC, Woods C, Butler CC, Faust SN, Leydon G, Wan M, Hood K, Whitehurst J, Richards-Hall S, Smith P, Thomas M, Moore M, Verheij T. Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial. Lancet. 2021 Oct 16;398(10309):1417-1426. doi: 10.1016/S0140-6736(21)01431-8. Epub 2021 Sep 22. PMID: 34562391; PMCID: PMC8542731.
Copy Download .nbib Format: NLM
[Late onset visual loss due to retinal atrophy in atypical mucolipidosis type IV].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft

Hoogmartens C, Rickmann A, Bocqué C, Szurman P, Boden KT.
PMID: 33502543
Ophthalmologe. 2022 Jan;119:90-92. doi: 10.1007/s00347-021-01322-7. Epub 2021 Jan 27.

No abstract available.

Cite
Hoogmartens C, Rickmann A, Bocqué C, et al. Late-onset-Visusverlust durch retinale Atrophie bei atypischer Mukolipidose Typ 4. [Late onset visual loss due to retinal atrophy in atypical mucolipidosis type IV]. Ophthalmologe. 2021;119:90-92doi: 10.1007/s00347-021-01322-7.
Hoogmartens, C., Rickmann, A., Bocqué, C., Szurman, P., & Boden, K. T. (2022). Late-onset-Visusverlust durch retinale Atrophie bei atypischer Mukolipidose Typ 4. [Late onset visual loss due to retinal atrophy in atypical mucolipidosis type IV]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 11990-92. https://doi.org/10.1007/s00347-021-01322-7
Hoogmartens, Caroline, et al. "Late-onset-Visusverlust durch retinale Atrophie bei atypischer Mukolipidose Typ 4." [Late onset visual loss due to retinal atrophy in atypical mucolipidosis type IV]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft vol. 119 (2022): 90-92. doi: https://doi.org/10.1007/s00347-021-01322-7
Hoogmartens C, Rickmann A, Bocqué C, Szurman P, Boden KT. Late-onset-Visusverlust durch retinale Atrophie bei atypischer Mukolipidose Typ 4. [Late onset visual loss due to retinal atrophy in atypical mucolipidosis type IV]. Ophthalmologe. 2022 Jan;119:90-92. doi: 10.1007/s00347-021-01322-7. Epub 2021 Jan 27. German. PMID: 33502543.
Copy Download .nbib Format: NLM
Fast one-dimensional wave-front propagation for x-ray differential phase-contrast imaging.

Biomedical optics express

Wolf J, Malecki A, Sperl J, Chabior M, Schüttler M, Bequé D, Cozzini C, Pfeiffer F.
PMID: 25360386
Biomed Opt Express. 2014 Sep 29;5(10):3739-47. doi: 10.1364/BOE.5.003739. eCollection 2014 Oct 01.

Numerical wave-optical simulations of X-ray differential phase-contrast imaging using grating interferometry require the oversampling of gratings and object structures in the range of few micrometers. Consequently, fields of view of few millimeters already use large amounts of a computer's...

Cite
Wolf J, Malecki A, Sperl J, et al. Fast one-dimensional wave-front propagation for x-ray differential phase-contrast imaging. Biomed Opt Express. 2014;5(10):3739-47doi: 10.1364/BOE.5.003739.
Wolf, J., Malecki, A., Sperl, J., Chabior, M., Schüttler, M., Bequé, D., Cozzini, C., & Pfeiffer, F. (2014). Fast one-dimensional wave-front propagation for x-ray differential phase-contrast imaging. Biomedical optics express, 5(10), 3739-47. https://doi.org/10.1364/BOE.5.003739
Wolf, Johannes, et al. "Fast one-dimensional wave-front propagation for x-ray differential phase-contrast imaging." Biomedical optics express vol. 5,10 (2014): 3739-47. doi: https://doi.org/10.1364/BOE.5.003739
Wolf J, Malecki A, Sperl J, Chabior M, Schüttler M, Bequé D, Cozzini C, Pfeiffer F. Fast one-dimensional wave-front propagation for x-ray differential phase-contrast imaging. Biomed Opt Express. 2014 Sep 29;5(10):3739-47. doi: 10.1364/BOE.5.003739. eCollection 2014 Oct 01. PMID: 25360386; PMCID: PMC4206338.
Copy Download .nbib Format: NLM
The admission of older patients to a dedicated short stay medical unit: learning from experience.

Acute medicine

Chu GS, Becque T, Bariana TK, Pereira SR, Hayman M, Haydock SF.
PMID: 21611586
Acute Med. 2007;6(3):121-3.

The admission of older patients with acute medical problems to short stay medical units (SSMUs) is controversial in light of their longer expected length of in-patient stay (LoS), coupled with the greater resources required by such a department. We...

Cite
Chu GS, Becque T, Bariana TK, et al. The admission of older patients to a dedicated short stay medical unit: learning from experience. Acute Med. 2007;6(3):121-3
Chu, G. S., Becque, T., Bariana, T. K., Pereira, S. R., Hayman, M., & Haydock, S. F. (2007). The admission of older patients to a dedicated short stay medical unit: learning from experience. Acute medicine, 6(3), 121-3.
Chu, Gavin S, et al. "The admission of older patients to a dedicated short stay medical unit: learning from experience." Acute medicine vol. 6,3 (2007): 121-3.
Chu GS, Becque T, Bariana TK, Pereira SR, Hayman M, Haydock SF. The admission of older patients to a dedicated short stay medical unit: learning from experience. Acute Med. 2007;6(3):121-3. PMID: 21611586.
Copy Download .nbib Format: NLM
[Conjunctival mantle cell lymphoma-a therapeutic challenge].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft

Trouvain AM, Bocqué C, Müller LJ, Heinrich C, Bewarder M, Pérez Guerra N, Szurman G, Becker SL, Rickmann A.
PMID: 34319474
Ophthalmologe. 2021 Jul 28; doi: 10.1007/s00347-021-01462-w. Epub 2021 Jul 28.

No abstract available.

Cite
Trouvain AM, Bocqué C, Müller LJ, et al. Konjunktivales Mantelzelllymphom – eine therapeutische Herausforderung. [Conjunctival mantle cell lymphoma-a therapeutic challenge]. Ophthalmologe. 2021;doi: 10.1007/s00347-021-01462-w.
Trouvain, A. M., Bocqué, C., Müller, L. J., Heinrich, C., Bewarder, M., Pérez Guerra, N., Szurman, G., Becker, S. L., & Rickmann, A. (2021). Konjunktivales Mantelzelllymphom – eine therapeutische Herausforderung. [Conjunctival mantle cell lymphoma-a therapeutic challenge]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, . https://doi.org/10.1007/s00347-021-01462-w
Trouvain, André M, et al. "Konjunktivales Mantelzelllymphom – eine therapeutische Herausforderung." [Conjunctival mantle cell lymphoma-a therapeutic challenge]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft vol. (2021). doi: https://doi.org/10.1007/s00347-021-01462-w
Trouvain AM, Bocqué C, Müller LJ, Heinrich C, Bewarder M, Pérez Guerra N, Szurman G, Becker SL, Rickmann A. Konjunktivales Mantelzelllymphom – eine therapeutische Herausforderung. [Conjunctival mantle cell lymphoma-a therapeutic challenge]. Ophthalmologe. 2021 Jul 28; doi: 10.1007/s00347-021-01462-w. Epub 2021 Jul 28. German. PMID: 34319474.
Copy Download .nbib Format: NLM
Dignity reflections based on experiences of end-of-life care during the first wave of the COVID-19 pandemic: A qualitative inquiry among bereaved relatives in the Netherlands (the CO-LIVE study).

Scandinavian journal of caring sciences

Becqué YN, van der Geugten W, van der Heide A, Korfage IJ, Pasman HRW, Onwuteaka-Philipsen BD, Zee M, Witkamp E, Goossensen A.
PMID: 34625992
Scand J Caring Sci. 2021 Oct 09; doi: 10.1111/scs.13038. Epub 2021 Oct 09.

BACKGROUND: The COVID-19 pandemic affects care practices for critically ill patients, with or without a COVID-19 infection, and may have affected the experience of dying for patients and their relatives in the physical, psychological, social and spiritual domains.AIM: To...

Cite
Becqué YN, van der Geugten W, van der Heide A, et al. Dignity reflections based on experiences of end-of-life care during the first wave of the COVID-19 pandemic: A qualitative inquiry among bereaved relatives in the Netherlands (the CO-LIVE study). Scand J Caring Sci. 2021;doi: 10.1111/scs.13038.
Becqué, Y. N., van der Geugten, W., van der Heide, A., Korfage, I. J., Pasman, H. R. W., Onwuteaka-Philipsen, B. D., Zee, M., Witkamp, E., & Goossensen, A. (2021). Dignity reflections based on experiences of end-of-life care during the first wave of the COVID-19 pandemic: A qualitative inquiry among bereaved relatives in the Netherlands (the CO-LIVE study). Scandinavian journal of caring sciences, . https://doi.org/10.1111/scs.13038
Becqué, Yvonne N, et al. "Dignity reflections based on experiences of end-of-life care during the first wave of the COVID-19 pandemic: A qualitative inquiry among bereaved relatives in the Netherlands (the CO-LIVE study)." Scandinavian journal of caring sciences vol. (2021). doi: https://doi.org/10.1111/scs.13038
Becqué YN, van der Geugten W, van der Heide A, Korfage IJ, Pasman HRW, Onwuteaka-Philipsen BD, Zee M, Witkamp E, Goossensen A. Dignity reflections based on experiences of end-of-life care during the first wave of the COVID-19 pandemic: A qualitative inquiry among bereaved relatives in the Netherlands (the CO-LIVE study). Scand J Caring Sci. 2021 Oct 09; doi: 10.1111/scs.13038. Epub 2021 Oct 09. PMID: 34625992; PMCID: PMC8661881.
Copy Download .nbib Format: NLM
Correction to: Diarrhoea Management using Over-thecounter Nutraceuticals in Daily practice (DIAMOND): a feasibility RCT on alternative therapy to reduce antibiotic use.

Pilot and feasibility studies

Hu YJ, Zhou X, Wang S, Willcox M, Garner C, Brown D, Becque T, Stuart B, Han Z, Chang Q, Moore M, Little P.
PMID: 34407892
Pilot Feasibility Stud. 2021 Aug 18;7(1):159. doi: 10.1186/s40814-021-00890-4.

No abstract available.

Cite
Hu YJ, Zhou X, Wang S, et al. Correction to: Diarrhoea Management using Over-thecounter Nutraceuticals in Daily practice (DIAMOND): a feasibility RCT on alternative therapy to reduce antibiotic use. Pilot Feasibility Stud. 2021;7(1):159doi: 10.1186/s40814-021-00890-4.
Hu, Y. J., Zhou, X., Wang, S., Willcox, M., Garner, C., Brown, D., Becque, T., Stuart, B., Han, Z., Chang, Q., Moore, M., & Little, P. (2021). Correction to: Diarrhoea Management using Over-thecounter Nutraceuticals in Daily practice (DIAMOND): a feasibility RCT on alternative therapy to reduce antibiotic use. Pilot and feasibility studies, 7(1), 159. https://doi.org/10.1186/s40814-021-00890-4
Hu, Yanhong Jessika, et al. "Correction to: Diarrhoea Management using Over-thecounter Nutraceuticals in Daily practice (DIAMOND): a feasibility RCT on alternative therapy to reduce antibiotic use." Pilot and feasibility studies vol. 7,1 (2021): 159. doi: https://doi.org/10.1186/s40814-021-00890-4
Hu YJ, Zhou X, Wang S, Willcox M, Garner C, Brown D, Becque T, Stuart B, Han Z, Chang Q, Moore M, Little P. Correction to: Diarrhoea Management using Over-thecounter Nutraceuticals in Daily practice (DIAMOND): a feasibility RCT on alternative therapy to reduce antibiotic use. Pilot Feasibility Stud. 2021 Aug 18;7(1):159. doi: 10.1186/s40814-021-00890-4. PMID: 34407892; PMCID: PMC8371852.
Copy Download .nbib Format: NLM
Clinical results after single asymmetrical shark fin for graft orientation in DMEK.

International ophthalmology

Rickmann A, Boden K, Trouvain AM, Müller LJ, Bocqué C, Thaler S, Szurman P.
PMID: 34718920
Int Ophthalmol. 2021 Oct 31; doi: 10.1007/s10792-021-02091-7. Epub 2021 Oct 31.

PURPOSE: Evaluating the effect of a single peripheral triangular mark to ensure the correct anterior-posterior graft orientation in DMEK.METHODS: Retrospective study of patients scheduled for DMEK due to Fuchs endothelial dystrophy and divided into 2 study groups: Group -M...

Cite
Rickmann A, Boden K, Trouvain AM, et al. Clinical results after single asymmetrical shark fin for graft orientation in DMEK. Int Ophthalmol. 2021;doi: 10.1007/s10792-021-02091-7.
Rickmann, A., Boden, K., Trouvain, A. M., Müller, L. J., Bocqué, C., Thaler, S., & Szurman, P. (2021). Clinical results after single asymmetrical shark fin for graft orientation in DMEK. International ophthalmology, . https://doi.org/10.1007/s10792-021-02091-7
Rickmann, Annekatrin, et al. "Clinical results after single asymmetrical shark fin for graft orientation in DMEK." International ophthalmology vol. (2021). doi: https://doi.org/10.1007/s10792-021-02091-7
Rickmann A, Boden K, Trouvain AM, Müller LJ, Bocqué C, Thaler S, Szurman P. Clinical results after single asymmetrical shark fin for graft orientation in DMEK. Int Ophthalmol. 2021 Oct 31; doi: 10.1007/s10792-021-02091-7. Epub 2021 Oct 31. PMID: 34718920.
Copy Download .nbib Format: NLM
Identification of CRF66_BF, a New HIV-1 Circulating Recombinant Form of South American Origin.

Frontiers in microbiology

Bacqué J, Delgado E, Benito S, Moreno-Lorenzo M, Montero V, Gil H, Sánchez M, Nieto-Toboso MC, Muñoz J, Zubero-Sulibarria MZ, Ugalde E, García-Bodas E, Cañada JE, Del Romero J, Rodríguez C, Rodríguez-Avial I, Elorduy-Otazua L, Portu JJ, García-Costa J, Ocampo A, Cabrera JJ, Thomson MM.
PMID: 34867914
Front Microbiol. 2021 Nov 15;12:774386. doi: 10.3389/fmicb.2021.774386. eCollection 2021.

Circulating recombinant forms (CRFs) are important components of the HIV-1 pandemic. Among 110 reported in the literature, 17 are BF1 intersubtype recombinant, most of which are of South American origin. Among these, all 5 identified in the Southern Cone...

Cite
Bacqué J, Delgado E, Benito S, et al. Identification of CRF66_BF, a New HIV-1 Circulating Recombinant Form of South American Origin. Front Microbiol. 2021;12:774386doi: 10.3389/fmicb.2021.774386.
Bacqué, J., Delgado, E., Benito, S., Moreno-Lorenzo, M., Montero, V., Gil, H., Sánchez, M., Nieto-Toboso, M. C., Muñoz, J., Zubero-Sulibarria, M. Z., Ugalde, E., García-Bodas, E., Cañada, J. E., Del Romero, J., Rodríguez, C., Rodríguez-Avial, I., Elorduy-Otazua, L., Portu, J. J., García-Costa, J., Ocampo, A., Cabrera, J. J., & Thomson, M. M. (2021). Identification of CRF66_BF, a New HIV-1 Circulating Recombinant Form of South American Origin. Frontiers in microbiology, 12774386. https://doi.org/10.3389/fmicb.2021.774386
Bacqué, Joan, et al. "Identification of CRF66_BF, a New HIV-1 Circulating Recombinant Form of South American Origin." Frontiers in microbiology vol. 12 (2021): 774386. doi: https://doi.org/10.3389/fmicb.2021.774386
Bacqué J, Delgado E, Benito S, Moreno-Lorenzo M, Montero V, Gil H, Sánchez M, Nieto-Toboso MC, Muñoz J, Zubero-Sulibarria MZ, Ugalde E, García-Bodas E, Cañada JE, Del Romero J, Rodríguez C, Rodríguez-Avial I, Elorduy-Otazua L, Portu JJ, García-Costa J, Ocampo A, Cabrera JJ, Thomson MM. Identification of CRF66_BF, a New HIV-1 Circulating Recombinant Form of South American Origin. Front Microbiol. 2021 Nov 15;12:774386. doi: 10.3389/fmicb.2021.774386. eCollection 2021. PMID: 34867914; PMCID: PMC8634668.
Copy Download .nbib Format: NLM
Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides.

Frontiers in medicine

Lepareur N, Leal E Costa L, Bocqué M, Blondelle C, Ruello C, Desjulets M, Noiret N, Cammas-Marion S.
PMID: 26389121
Front Med (Lausanne). 2015 Sep 04;2:63. doi: 10.3389/fmed.2015.00063. eCollection 2015.

INTRODUCTION: Encapsulation of biologically active molecules into nanoparticles (NPs), for site-specific delivery, is a fast growing area. These NPs must be biocompatible, non-toxic, and able to release their load in a controlled way. We have developed a series of...

Cite
Lepareur N, Leal E Costa L, Bocqué M, et al. Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides. Front Med (Lausanne). 2015;2:63doi: 10.3389/fmed.2015.00063.
Lepareur, N., Leal E Costa, L., Bocqué, M., Blondelle, C., Ruello, C., Desjulets, M., Noiret, N., & Cammas-Marion, S. (2015). Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides. Frontiers in medicine, 263. https://doi.org/10.3389/fmed.2015.00063
Lepareur, Nicolas, et al. "Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides." Frontiers in medicine vol. 2 (2015): 63. doi: https://doi.org/10.3389/fmed.2015.00063
Lepareur N, Leal E Costa L, Bocqué M, Blondelle C, Ruello C, Desjulets M, Noiret N, Cammas-Marion S. Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides. Front Med (Lausanne). 2015 Sep 04;2:63. doi: 10.3389/fmed.2015.00063. eCollection 2015. PMID: 26389121; PMCID: PMC4559641.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries